Cardinal Health, Inc. $CAH Shares Purchased by CHURCHILL MANAGEMENT Corp

CHURCHILL MANAGEMENT Corp raised its stake in Cardinal Health, Inc. (NYSE:CAH) by 0.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 242,896 shares of the company’s stock after purchasing an additional 1,057 shares during the quarter. Cardinal Health comprises about 0.4% of CHURCHILL MANAGEMENT Corp’s investment portfolio, making the stock its 25th biggest position. CHURCHILL MANAGEMENT Corp owned 0.10% of Cardinal Health worth $40,807,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of CAH. JPMorgan Chase & Co. lifted its position in shares of Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Cardinal Health by 3.5% in the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after acquiring an additional 105,154 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Cardinal Health by 3.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after purchasing an additional 52,714 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Cardinal Health by 0.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock worth $171,749,000 after purchasing an additional 7,940 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

CAH opened at $157.79 on Thursday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The business has a 50 day moving average price of $152.11 and a 200 day moving average price of $149.90. The firm has a market cap of $37.49 billion, a P/E ratio of 24.46, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s payout ratio is presently 31.63%.

Insider Buying and Selling at Cardinal Health

In other news, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jason M. Hollar sold 107,705 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the sale, the chief executive officer owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 in the last ninety days. 0.12% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have commented on the stock. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird boosted their price objective on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a report on Wednesday, August 13th. Citigroup reiterated a “neutral” rating and set a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Bank of America lifted their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, June 10th. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Eleven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.